Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Updated: Mar 30 2023

Alkylating Agents

  • Overview
      • Alkylating Agents
      • Mechanism of Action
      • Cyclophosphamide and ifosfamide
      • Crosslinks DNA 
      • Hemorrhagic cytitis and myelosupression
      • Nitrosoureas
      • Crosslinks DNA
      • Dizziness and ataxia
      • Busulfan
      • Alkylates DNA
      • Pulmonary fibrosis and hyperpigmentation
  • Cyclophosphamide and Ifosfamide
    • Mechanism
      • covalently crosslinks DNA
        • at guanine N7 position
        • between strands and within strands
      • requires bioactivation by liver
    • Clinical use
      • non-Hodgkin's lymphoma
      • breast cancer
      • ovarian cancer
      • immunosuppression
    • Toxicity
      • hemorrhagic cystitis
        • prevent with mesna or N-acetylcysteine
          • thiol group binds acrolein, a toxic metabolite
      • myelosuppression
  • Nitrosoureas (Carmustine, Lomustine, Semustine, and Streptozocin)
    • Mechanism
      • crosslinks DNA
      • crosses BBB and enters CNS
      • requires bioactivation
    • Clinical use
      • brain tumors
        • including glioblastoma multiforme
    • Toxicity
      • CNS toxicity
        • dizziness
        • ataxia
  • Busulfan
    • Mechanism
      • alkylates DNA
    • Clinical use
      • CML
        • was gold standard before imatinib was discovered
      • hematopoietic stem cell transplants
        • used for bone marrow ablation
    • Toxicity
      • pulmonary fibrosis
      • hyperpigmentation
Card
1 of 0
Question
1 of 2
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options